As highlighted by Kurt S. Altrichter, Big Pharma is heading toward a $440 billion patent cliff. And this is bullish

Written by Charles-Henry Monchau, CFA, CMT, CAIA | Aug 31, 2026, 2:06:49 PM

View full post